Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Diabetic ketoacidosis (DKA) is still a major contributor to morbidity and mortality in diabetes. The triad of hyperglycaemia, ketosis and acidosis can be diagnosed within a few minutes of the patient presenting, by measuring blood glucose and ketones using a meter, and venous blood pH on a blood gas analyser. Quantifying ketosis allows accurate distinction between simple hyperglycaemia and metabolic decompensation. We review the management of DKA, and the emerging role of near-patient testing in diagnosing ketosis and monitoring its resolution.

Original publication

DOI

10.1093/qjmed/hch132

Type

Journal article

Journal

QJM

Publication Date

12/2004

Volume

97

Pages

773 - 780

Keywords

Blood Glucose, Diabetic Ketoacidosis, Humans, Hypoglycemic Agents, Insulin, Ketone Bodies, Long-Term Care, Potassium